Q1 2022 Rhythm Pharmaceuticals Inc Earnings Call Transcript
Welcome to the Rhythm Pharmaceuticals First Quarter 2022 Earnings Conference Call. My name is Hilda, and I will be your operator for today's call. (Operator Instructions)
I will now turn the call over to Mr. David Connolly, Investor Relations & Corporate Communications. You may begin.
Thank you, and good morning, everybody. I'm Dave Connolly, Head of IR and Corporate Communications here at Rhythm Pharmaceuticals. For those of you participating via the conference call, the accompanying slides can be accessed and controlled by going to the Events section of the Investor's page on our website at ir.rhythmtx.com.
This morning we issued a press release that provides our first quarter and first quarter 2022 financial results and business update, which is available on our website. And as listed on Slide 2, today here with me in Boston for the conference call are David Meeker, Chair, President and Chief Executive Officer of Rhythm; Jennifer Chien, Executive
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |